131 related articles for article (PubMed ID: 9811167)
41. Pressor and renal vasoconstrictor effects of NG-nitro-L-arginine as affected by blockade of pressor mechanisms mediated by the sympathetic nervous system, angiotensin, prostanoids and vasopressin.
Pucci ML; Lin L; Nasjletti A
J Pharmacol Exp Ther; 1992 Apr; 261(1):240-5. PubMed ID: 1560371
[TBL] [Abstract][Full Text] [Related]
42. Role of prostaglandin, endothelin and sympathetic nervous system on the L-NAME-induced pressor responses in spontaneously hypertensive rats.
Salas N; Terrell ML; Summy-Long JY; Kadekaro M
Brain Res; 2003 Sep; 983(1-2):162-73. PubMed ID: 12914977
[TBL] [Abstract][Full Text] [Related]
43. Renal hemodynamic and excretory responses in anesthetized rats to FK409, a novel nitric oxide donor.
Urabe K; Matsumura Y; Nishiura M; Maeda K; Morimoto S
Eur J Pharmacol; 1997 Feb; 321(2):195-200. PubMed ID: 9063688
[TBL] [Abstract][Full Text] [Related]
44. Use of A-192621 and IRL-2500 to unmask the mesenteric and renal vasodilator role of endothelin ET(B) receptors.
Leung SW; Lim SL; Pang CC; Man RY
J Cardiovasc Pharmacol; 2002 Apr; 39(4):533-43. PubMed ID: 11904527
[TBL] [Abstract][Full Text] [Related]
45. Acute intravenous injection and short-term oral administration of N(G) -nitro-L-arginine methyl ester to the rat provoke increased pressor responses to agonists and hypertension, but not inhibition of acetylcholine-induced hypotensive responses.
López RM; Pérez T; Castillo C; Castillo MC; Castillo EF
Fundam Clin Pharmacol; 2011 Jun; 25(3):333-42. PubMed ID: 20608990
[TBL] [Abstract][Full Text] [Related]
46. Vasopressin does not effect hypertension caused by long-term nitric oxide inhibition.
Loichot C; Cazaubon C; Grima M; De Jong W; Nisato D; Imbs JL; Barthelmebs M
Hypertension; 2000 Feb; 35(2):602-8. PubMed ID: 10679504
[TBL] [Abstract][Full Text] [Related]
47. Nitric oxide regulation of TP receptor-mediated pulmonary vasoconstriction in the anesthetized, open-chest rat.
Valentin JP; Bessac AM; Maffre M; John GW
Eur J Pharmacol; 1996 Dec; 317(2-3):335-42. PubMed ID: 8997619
[TBL] [Abstract][Full Text] [Related]
48. Interactive effects of superoxide anion and nitric oxide on blood pressure and renal hemodynamics in transgenic rats with inducible malignant hypertension.
Patterson ME; Mouton CR; Mullins JJ; Mitchell KD
Am J Physiol Renal Physiol; 2005 Oct; 289(4):F754-9. PubMed ID: 15900020
[TBL] [Abstract][Full Text] [Related]
49. Endothelin at pathophysiological concentrations mediates coronary vasoconstriction via the endothelin-A receptor.
Cannan CR; Burnett JC; Brandt RR; Lerman A
Circulation; 1995 Dec; 92(11):3312-7. PubMed ID: 7586319
[TBL] [Abstract][Full Text] [Related]
50. Effects of L-NOARG on plus-maze performance in rats.
De Oliveira CL; Del Bel EA; Guimarães FS
Pharmacol Biochem Behav; 1997 Jan; 56(1):55-9. PubMed ID: 8981609
[TBL] [Abstract][Full Text] [Related]
51. The influence of the nitric oxide synthase inhibitor L-NOARG on the effects of ethanol in rats after acute ethanol administration.
Vassiljev V; Mesila I; Väli M; Pokk P
Pharmacol Toxicol; 2000 Feb; 86(2):63-7. PubMed ID: 10728916
[TBL] [Abstract][Full Text] [Related]
52. Enhanced superoxide activity modulates renal function in NO-deficient hypertensive rats.
Kopkan L; Majid DS
Hypertension; 2006 Mar; 47(3):568-72. PubMed ID: 16401762
[TBL] [Abstract][Full Text] [Related]
53. Effects of endothelin receptor antagonists and nitric oxide on myogenic tone and alpha-adrenergic-dependent contractions of rabbit resistance arteries.
Nguyen TD; Véquaud P; Thorin E
Cardiovasc Res; 1999 Aug; 43(3):755-61. PubMed ID: 10690347
[TBL] [Abstract][Full Text] [Related]
54. Renoprotective effects of nitric oxide in angiotensin II-induced hypertension in the rat.
Chin SY; Wang CT; Majid DS; Navar LG
Am J Physiol; 1998 May; 274(5):F876-82. PubMed ID: 9612324
[TBL] [Abstract][Full Text] [Related]
55. FR139317, a specific ETA-receptor antagonist, inhibits cerebral activation by intraventricular endothelin-1 in conscious rats.
Gross PM; Weaver DF; Ho LT; Pang JJ; Edvinsson L
Neuropharmacology; 1994 Oct; 33(10):1155-66. PubMed ID: 7862251
[TBL] [Abstract][Full Text] [Related]
56. Role of endothelin ET(B) receptors in the renal hemodynamic and excretory responses to big endothelin-1.
Konishi F; Okada Y; Takaoka M; Gariepy CE; Yanagisawa M; Matsumura Y
Eur J Pharmacol; 2002 Sep; 451(2):177-84. PubMed ID: 12231389
[TBL] [Abstract][Full Text] [Related]
57. Amelioration of post-ischaemic renal injury by contralateral uninephrectomy: a role of endothelin-1.
Kato A; Hishida A
Nephrol Dial Transplant; 2001 Aug; 16(8):1570-6. PubMed ID: 11477157
[TBL] [Abstract][Full Text] [Related]
58. Tolerance to the cataleptic effect that follows repeated nitric oxide synthase inhibition may be related to functional enzymatic recovery.
Del-Bel EA; Guimarães FS; Joca SR; Echeverry MB; Ferreira FR
J Psychopharmacol; 2010 Mar; 24(3):397-405. PubMed ID: 18838497
[TBL] [Abstract][Full Text] [Related]
59. Endothelin-A receptors and NO mediate decrease in arterial pressure during recovery from restraint.
Yip AW; Krukoff TL
Am J Physiol Regul Integr Comp Physiol; 2002 Mar; 282(3):R881-9. PubMed ID: 11832411
[TBL] [Abstract][Full Text] [Related]
60. Role of endogenous endothelins in catecholamine secretion in the rat adrenal gland.
Nagayama T; Kuwakubo F; Matsumoto T; Fukushima Y; Yoshida M; Suzuki-Kusaba M; Hisa H; Matsumura Y; Kimura T; Satoh S
Eur J Pharmacol; 2000 Oct; 406(1):69-74. PubMed ID: 11011035
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
